BOSENTAN

Post-LOE

bosentan

ANDAORALTABLET
Approved
Apr 2019
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
8

Mechanism of Action

. Bosentan has a slightly higher affinity for ET A receptors than for ET B receptors. The clinical impact of dual endothelin blockage is unknown. Endothelin-1 (ET-1) is a neurohormone, the effects of which are mediated by binding to ET A and ET B receptors in the endothelium and vascular smooth…

Clinical Trials (5)

NCT07081932Phase 1Completed

A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood

Started Aug 2025
16 enrolled
Healthy
NCT05723874Phase 1Completed

A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood

Started Mar 2023
14 enrolled
Healthy
NCT04991207Phase 1Completed

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan

Started Feb 2018
NCT02667704Phase 1Completed

Influence of Bosentan on the Pharmacokinetics of Nintedanib

Started Feb 2016
13 enrolled
Healthy
NCT01425229N/ACompleted

Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin

Started Jun 2011
16 enrolled
Drug Interactions